Evidence map›Paper›PMID 30150674›Full record

ArticleScientific reports2018

Metabolic reprogramming of stromal fibroblasts by melanoma exosome microRNA favours a pre-metastatic microenvironment.

Shin La Shu, Yunchen Yang, Cheryl L Allen, Orla Maguire, Hans Minderman, Arindam Sen, Michael J Ciesielski, Katherine A Collins, Peter J Bush, Prashant Singh and 7 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 124 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
124citing papers in PubMed, 1 pooled it
8.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

124 citing papers in PubMed, 1 synthesis or guideline pooled it, 167 citations in OpenAlex.

  1. The Roles of MiRNAs (MicroRNAs) in Melanoma Immunotherapy.International journal of molecular sciences · 2022
    Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Introduction to Cancer Metabolism.Cancer treatment and research · 2026
    Review
  8. Extracellular vesicles as modulators of cancer metabolism and microenvironment.Extracellular vesicles and circulating nucleic acids · 2026
    Review
  9. Metabolic reprogramming and plasticity of cancer stem cells.Frontiers in cell and developmental biology · 2026
    Review
  10. Article
  11. Review
  12. Review
  13. New insights into extracellular vesicles in metastatic cancer: From mechanisms to diagnostics and targeted therapies.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Review
  14. Mitochondrial bioenergetics and networks in melanoma: an update.Apoptosis : an international journal on programmed cell death · 2025
    Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review

64 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 1 country.

Shin La ShuDepartment of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Yunchen YangDepartment of Biomedical Engineering, Jacobs School of Medicine & Biomedical Sciences, University at Buffalo, The State University of New York, Buffalo, NY, USA.
Cheryl L AllenDepartment of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Orla MaguireFlow and Image Cytometry Shared Resource, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Hans MindermanFlow and Image Cytometry Shared Resource, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Arindam SenDepartment of Cell Stress Biology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Michael J CiesielskiDepartment of Neurosurgery, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Katherine A CollinsImmune Analysis Facility, Center for Immunotherapy, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Peter J BushSouth Campus Instrumentation Center, University at Buffalo, The State University of New York, Buffalo, NY, USA.
Prashant SinghGenomics Shared Resource, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Xue WangNew York Center of Excellence in Bioinformatics and Life Sciences, Buffalo, NY, USA.
Martin MorganDepartment of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Jun QuGenomics Shared Resource, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Richard B BankertDepartment of Microbiology and Immunology, Jacobs School of Medicine & Biomedical Sciences, University at Buffalo, The State University of New York, Buffalo, NY, USA.
Theresa L WhitesideDepartment of Pathology, Immunology and Otolaryngology, University of Pittsburgh School of Medicine and UPMC Hillman Cancer Center, Pittsburgh, PA, USA.
Yun WuDepartment of Biomedical Engineering, Jacobs School of Medicine & Biomedical Sciences, University at Buffalo, The State University of New York, Buffalo, NY, USA.
Marc S ErnstoffDepartment of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA. Marc.Ernstoff@RoswellPark.org.
Roswell Park Comprehensive Cancer Center · USUniversity at Buffalo, State University of New York · USCenter for Excellence in Education · USUPMC Hillman Cancer Center · US

Funding

Two-Spirit Films in Indigenous Cancer HealthP30CA016056 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI Dean G. Tang · 1985 to 2026
$116.6M
Associate-Director Flow and Image Cytometry Roswell Park ComprehensiveCancer CenterR50CA211108 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI HANS MINDERMAN · 2016 to 2026
$3.0M
Restoring anti-tumor immunity in the microenvironment of head and neck cancerR01CA168628 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI WHITESIDE, THERESA L. · 2013 to 2017
$1.7M
Noninvasive detection of circulating RNAs for lung cancer early detection and prognosisR33CA191245 · NCI · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI WU, YUN · 2015 to 2018
$1.3M
Imaging Flow CytometerS10OD018048 · OD · ROSWELL PARK CANCER INSTITUTE CORP · PI MINDERMAN, HANS · 2014 to 2014
$400k
(PQ11) Reversing exosome-mediated immune suppression - a novel strategy for cancer therapyR21CA205644 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BOYIADZIS, MICHAEL, WHITESIDE, THERESA L. · 2016 to 2017
$370k
NCI NIH HHS P30 CA016056NCI NIH HHS R01 CA168628NCI NIH HHS R21 CA205644NCI NIH HHS R33 CA191245NCI NIH HHS R50 CA211108NIH HHS S10 OD018048U.S. Department of Health & Human Services | National Institutes of Health (NIH) 1R50CA211108U.S. Department of Health & Human Services | National Institutes of Health (NIH) P30CA016056U.S. Department of Health & Human Services | National Institutes of Health (NIH) S10OD018048U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) 5R33CA191245U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) CA205644U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) P30CA016056
6 · The paper itself

Abstract

Local acidification of stroma is proposed to favour pre-metastatic niche formation but the mechanism of initiation is unclear. We investigated whether Human Melanoma-derived exosomes (HMEX) could reprogram human adult dermal fibroblasts (HADF) and cause extracellular acidification. HMEX were isolated from supernatants of six melanoma cell lines (3 BRAF V600E mutant cell lines and 3 BRAF wild-type cell lines) using ultracentrifugation or Size Exclusion Chromatography (SEC). Rapid uptake of exosomes by HADF was demonstrated following 18 hours co-incubation. Exposure of HDAF to HMEX leads to an increase in aerobic glycolysis and decrease in oxidative phosphorylation (OXPHOS) in HADF, consequently increasing extracellular acidification. Using a novel immuno-biochip, exosomal miR-155 and miR-210 were detected in HMEX. These miRNAs were present in HMEX from all six melanoma cell lines and were instrumental in promoting glycolysis and inhibiting OXPHOS in tumour cells. Inhibition of miR-155 and miR-210 activity by transfection of miRNA inhibitors into HMEX reversed the exosome-induced metabolic reprogramming of HADF. The data indicate that melanoma-derived exosomes modulate stromal cell metabolism and may contribute to the creation of a pre-metastatic niche that promotes the development of metastasis.

Indexed as

AerobiosisCell Line, TumorCellular ReprogrammingExosomesFibroblastsGene Expression Regulation, NeoplasticGlycolysisHumansMelanomaMicroRNAsTumor MicroenvironmentMicroRNAsMIRN155 microRNA, humanMIRN210 microRNA, human

Identifiers

PMID30150674
PMCPMC6110845
OpenAlexW2888447073

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.